Antibody-mediated rejection of renal allograft in combined liver-kidney transplant

Clinical Transplantation

Volumn 24, Issue 5, 2010, Pages 685-690

  Barth, Rolf N ^a   Campos, Luis ^a   Kukuruga, Debra L ^a   Drachenberg, Cinthia ^a   Philosophe, Benjamin ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

C4d; Cross reactive groups; Donor specific antibody; Humoral; Sensitized

Indexed keywords

ALLOANTIBODY; BASILIXIMAB; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; GRAFT RECIPIENT; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; KIDNEY LIVER TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; OLIGURIA; PLASMAPHERESIS; PRIORITY JOURNAL; SENSITIZATION;

ABO BLOOD-GROUP SYSTEM; COMPLEMENT C4B; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650505608     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01161.x     Document Type: Article

References (17)

1. Neumann UP, Lang M, Moldenhauer A et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001: 71: 1163.
2. Watson R, Kozlowski T, Nickeleit V et al. Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant 2006: 6: 3022.
3. Katznelson S, Cecka JM. The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation 1996: 61: 1403.
4. Saidman SL, Duquesnoy RJ, Demetris AJ et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994: 2: 61.
5. Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 2003: 76: 348.
6. Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS Database. Transplantation 2006: 82: 1298.
7. Morrissey PE, Gordon F, Shaffer D et al. Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998: 4: 363.
8. Faenza A, Fuga G, Nardo B et al. Combined liver-kidney transplantation: the experience of the University of Bologna and the case of preoperative positive cross-match. Transplant Proc 2006: 38: 1118.
9. Mosconi G, Scolari MP, Feliciangeli G et al. Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report. Transplant Proc 2006: 38: 1125.
10. Creput C, Durrbach A, Samuel D et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003: 3: 348.
11. Ruiz R, Kunitake H, Wilkinson AH et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006: 141: 735.
12. McAlister CC, Gao ZH, McAlister VC et al. Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation. Liver Transpl 2004: 10: 315.
13. Olausson M, Mjornstedt L, Norden G et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007: 7: 130.
14. Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 2007: 50: 739.
15. Wade JA, Hurley CK, Takemoto SK et al. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood 2007: 109: 4064.
16. Laux G, Opelz G. Immunological relevance of CREG matching in cadaver kidney transplantation. Transplantation 2004: 78: 442.
17. Stobbe I, Van Der Meer-Prins EM, De Lange P et al. Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys. Transplantation 2000: 70: 157.